Diabetes Care:I型糖尿病患者在闭环胰岛素给药期间所需胰岛素量的变化

2016-03-13 fsy 译 MedSci原创

该研究的目的是量化在闭环式胰岛素给药期间胰岛素需要量的变化。在一项多中心闭环试验中,研究人员回顾性分析了32名成人1型糖尿病患者的夜间,白天,以及全天胰岛素用量。参与者混合日夜闭环胰岛素给药,在自由生活的家庭条件下进行,时间超过12周。变化系数通过测量个体受试者的胰岛素需求变化获得。数据来自于1918个夜晚,1883个白天以及1,564个全天时间段进行分析,这些时间段通过超过85%的时间的闭环使用

该研究的目的是量化在闭环式(CL)胰岛素给药期间胰岛素需求量的变化。

在一项多中心闭环试验中,研究人员回顾性分析了32名成人1型糖尿病患者的夜间、白天以及全天胰岛素用量。参与者混合日夜闭环胰岛素给药,在自由生活的家庭条件下进行,时间超过12周。变化系数通过测量个体受试者的胰岛素需求变化获得。

数据来自于1918个夜晚、1883个白天以及1,564个全天时间段,分析这些时间段通过超过85%的时间的闭环使用分类。夜间胰岛素需要量变化(平均[SD]变化系数31%[4])几乎是总的每日所需量的2倍(17%[3],P<0.001),也比白天胰岛素需要量的变化要高(22%[4],P<0.001)。

夜间胰岛素需求量均显著多于白天和总的每天需求量。这也许可以解释为什么有些1型糖尿病患者报告的早晨血糖的变化总是不尽如人意。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1637289, encodeId=b30f163e2895a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 28 18:00:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749593, encodeId=3a031e49593f9, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Aug 14 17:00:00 CST 2016, time=2016-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759645, encodeId=b3711e5964505, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed May 25 21:00:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901356, encodeId=60d219013569c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jul 04 08:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473959, encodeId=7c6e14e3959d2, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Tue Mar 15 02:00:00 CST 2016, time=2016-03-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1637289, encodeId=b30f163e2895a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 28 18:00:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749593, encodeId=3a031e49593f9, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Aug 14 17:00:00 CST 2016, time=2016-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759645, encodeId=b3711e5964505, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed May 25 21:00:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901356, encodeId=60d219013569c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jul 04 08:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473959, encodeId=7c6e14e3959d2, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Tue Mar 15 02:00:00 CST 2016, time=2016-03-15, status=1, ipAttribution=)]
    2016-08-14 baoya
  3. [GetPortalCommentsPageByObjectIdResponse(id=1637289, encodeId=b30f163e2895a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 28 18:00:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749593, encodeId=3a031e49593f9, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Aug 14 17:00:00 CST 2016, time=2016-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759645, encodeId=b3711e5964505, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed May 25 21:00:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901356, encodeId=60d219013569c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jul 04 08:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473959, encodeId=7c6e14e3959d2, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Tue Mar 15 02:00:00 CST 2016, time=2016-03-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1637289, encodeId=b30f163e2895a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 28 18:00:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749593, encodeId=3a031e49593f9, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Aug 14 17:00:00 CST 2016, time=2016-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759645, encodeId=b3711e5964505, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed May 25 21:00:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901356, encodeId=60d219013569c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jul 04 08:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473959, encodeId=7c6e14e3959d2, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Tue Mar 15 02:00:00 CST 2016, time=2016-03-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1637289, encodeId=b30f163e2895a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 28 18:00:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749593, encodeId=3a031e49593f9, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Aug 14 17:00:00 CST 2016, time=2016-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759645, encodeId=b3711e5964505, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed May 25 21:00:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901356, encodeId=60d219013569c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jul 04 08:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473959, encodeId=7c6e14e3959d2, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Tue Mar 15 02:00:00 CST 2016, time=2016-03-15, status=1, ipAttribution=)]

相关资讯

这次3D打印技术要让Ⅰ型糖尿病患者受益啦!

对于Ⅰ型糖尿病患者来说,“胰岛移植”这种实验性手术也许可以帮助他们解决胰岛素缺乏的问题。这种手术将健康捐献者的胰岛细胞移植到Ⅰ型糖尿病患者体内,但是带来的副作用则是患者需要终身服用免疫抑制类药物以防止身体对外来植入细胞产生排斥反应。最近,科学家找到了一种新的办法–利用3D打印的支架对移植胰岛细胞进行保护。这种技术展示出了巨大潜力,有望帮助Ⅰ型糖尿病患者更轻松的管理自己的疾病。 Ⅰ型糖尿病

EBioMedicine:干细胞教育治疗成功诱导I型糖尿病患者免疫耐受

众所周知,I型糖尿病与免疫有关,而干细胞,尤其是成体干细胞可能具有诱导免疫耐受和免疫抑制作用。目前用于移植免疫治疗等,取得不错的结果。那么,能否用于I型糖尿病治疗呢? 美国最新一项临床1/2期试验,采用多潜能脐带血源干细胞(cord blood-derived multipotent stem cells,CB-SCs),采用干细胞教育治疗( Stem Cell Educato

NEJM:Ⅰ型糖尿病患者血糖控制情况影响死亡率

Ⅰ型糖尿病患者血糖控制情况影响死亡率背景对血糖控制在不同水平的Ⅰ型糖尿病患者而言,我们无法得知除了心血管疾病引起的死亡之外是否还有引起死亡的高风险因素,我们进行了一项对病人进行登记注册并追踪的观察性研究,进而探究瑞典处于不同血糖控制水平的糖尿病患者存在的引起死亡的高风险因素。方式我们选取的实验组成员是从1998年1月1日起至以后在瑞典国家糖尿病中心登记注册的Ⅰ型糖尿病患者,从普通人群中随机选取了五

Endocrinology:研究人员发现预防I型糖尿病的方法

由圣路易斯大学药理和生理科学主席托马斯•伯里斯博士报告的,一项发表在内分泌学上的新研究显示,他的团队在动物模型上已经找到了一种方法来防止I型糖尿病。 I型糖尿病是一种慢性自身免疫性疾病,当人体的免疫系统破坏胰岛素产生的胰腺β细胞时会导致I型糖尿病,表观为胰岛素缺乏和高血糖。目前治疗I型糖尿病关注点在通过胰岛素治疗控制血糖,但整个一生必须继续这种治疗。 伯里斯和他的研究小组专注研究阻止因β细胞损

Technology:高敏感微球检测技术或可用于I型糖尿病的早期诊断

近日,来自麻省总医院的科学家通过研究开发了一种基于荧光的新型检测手段,借助该手段利用几微升的血清样本就可以对抗体的敏感性进行检测,检测的敏感性至少是传统放射性免疫检测敏感性的50多倍,传统的放射性免疫测定手段是当前临床上常用的金标准,相关研究刊登于国际杂志TECHNOLOGY上。这项新型检测手段对于免疫学试验具有较大的吸引力,因为其可以:1)样本的用量较少;2)也是基于传统的分析系统,比如标准

人工器官用于Ⅰ型糖尿病有潜力

 人工胰腺可以防止糖尿病患者在睡眠时产生低血糖症状。图片来源:剑桥大学代谢研究实验室2013年4月的一个早晨,一位名叫Jane的女人在英国剑桥阿登布鲁克医院办理了出院手续。在过去的24小时里,她的身体通过一些管子与医疗设备相连并进行治疗。出院后,她将这些设备带回家,希望因此摆脱困扰她30年的I型糖尿病。小盒子这些设备包括一个胰岛素泵、一台血糖传感器和一个平装书大小的计算机,从而组成了